Description
BLOOD BANK REAGENTS AND SUPPLIES
First action · last action
2016-05-13 · 2019-04-30
Transactions
4
First transaction's obligation
$89,104
Base + all options value (sum of deltas)
$478,215
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA25515A0029
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2016-05-13+$89,104= $89,104
- Mod P000012016-08-20+$3,413= $92,517
- Mod P000022017-11-07-$14,663= $77,854
- Mod P000032019-04-30-$4,363= $73,491
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2016-05-13 | +$89,104 | $89,104 | BLOOD BANK REAGENTS AND SUPPLIES |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2016-08-20 | +$3,413 | $92,517 | BLOOD BANK REAGENTS AND SUPPLIES |
| Mod P00002· FUNDING ONLY ACTION | 2017-11-07 | −$14,663 | $77,854 | BLOOD BANK REAGENTS AND SUPPLIES |
| Mod P00003· FUNDING ONLY ACTION | 2019-04-30 | −$4,363 | $73,491 | BLOOD BANK REAGENTS AND SUPPLIES |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI V6KNKL6BDHL7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25526N0306 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $40,949 | FY2026 |
| 36C25926N0280 | NETWORK CONTRACT OFFICE 19 (36C259) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $64,078 | FY2026 |
| 36C25726N0176 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $7,634 | FY2026 |
| 36C25726N0224 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $16,514 | FY2026 |
| 36C25626N0214 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $23,127 | FY2026 |
| 36C25026N0043 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $21,884 | FY2026 |
Other recipients under 6640 from 255-NETWORK CONTRACT OFFICE 15 (36C255) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25526A0038 | SIEMENS HEALTHCARE DIAGNOSTICS INC. | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $0 | FY2026 |
| 36C25526N0419 | SIEMENS HEALTHCARE DIAGNOSTICS INC. | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $206,949 | FY2026 |
| 36C25526N0374 | ABBOTT LABORATORIES INC. | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $881,319 | FY2026 |
| 36C25526N0387 | ABBOTT LABORATORIES INC. | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $165,764 | FY2026 |
| 36C25526N0379 | WERFEN USA LLC | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $671,956 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25516J2940_3600_VA25515A0029_3600 · retrieved 2026-09-26.